Table 3.

CMV-Induced Factor(s) Impairs the Lymphocyte Proliferative Response to Mitogens and Recall Antigen

Mock PreparationCell-Free HCMVInhibition (%)P ValueMock CMCMV CMInhibition (%)P Value
Mitogens (day 3) 
Control medium 2.2 ± 1.23-150 1.7 ± 0.83-150   2.4 ± 0.63-150 2.0 ± 1.03-150 
PHA 193.9 ± 16.1 137.2 ± 11.7 29 ± 13-151 <.0013-152 189.2 ± 19.8 130.5 ± 22.8 31 ± 53-151 <.0013-152 
PWM 58.7 ± 15.5 45.1 ± 11.2 23 ± 5 .026 63.0 ± 16.5 43.3 ± 12.5 32 ± 4 .005 
Recall antigen (day 6) 
Control medium 33.9 ± 18.0 15.2 ± 9.2   45.4 ± 19.4 11.2 ± 6.5 
TT 124.4 ± 15.1 61.5 ± 16.9 51 ± 9 <.001 121.9 ± 18.6 80.1 ± 16.5 35 ± 6 <.001 
Mock PreparationCell-Free HCMVInhibition (%)P ValueMock CMCMV CMInhibition (%)P Value
Mitogens (day 3) 
Control medium 2.2 ± 1.23-150 1.7 ± 0.83-150   2.4 ± 0.63-150 2.0 ± 1.03-150 
PHA 193.9 ± 16.1 137.2 ± 11.7 29 ± 13-151 <.0013-152 189.2 ± 19.8 130.5 ± 22.8 31 ± 53-151 <.0013-152 
PWM 58.7 ± 15.5 45.1 ± 11.2 23 ± 5 .026 63.0 ± 16.5 43.3 ± 12.5 32 ± 4 .005 
Recall antigen (day 6) 
Control medium 33.9 ± 18.0 15.2 ± 9.2   45.4 ± 19.4 11.2 ± 6.5 
TT 124.4 ± 15.1 61.5 ± 16.9 51 ± 9 <.001 121.9 ± 18.6 80.1 ± 16.5 35 ± 6 <.001 

The proliferative response of PBMC incubated with cell-free inactivated HCMV was compared with the proliferative response of PBMC incubated with CMV CM. The inactivated HCMV and the mock preparation or the day 2 CMV CM and the mock CM were added at day 0 and maintained in culture.

F3-150

3H-thymidine incorporation assays are shown as the mean cpm/well ± SD multiplied per 103, obtained with 3 different PBMC cultures from HCMV seronegative donors. Each assay was done in triplicate.

F3-151

Percentage of inhibition = 100 minus (value obtained with HCMV or CMV CM/its mock control multiplied by 100).

F3-152

P value, comparing the proliferative response obtained with cell-free HCMV or CMV CM with their respective mock control.

or Create an Account

Close Modal
Close Modal